Chikungunya Treatment Market Size

  • Report ID: 3573
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Chikungunya Treatment Market Size

Chikungunya Treatment Market size was over USD 1.73 billion in 2023 and is poised to cross USD 3.03 billion by 2036, growing at more than 4.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of chikungunya treatment is evaluated at USD 1.79 billion. The growth of the market can be attributed to the growing occurrence of chikungunya, and rise in awareness about mosquito-transmitted infections around the world. According to the World Health Organization, Asia and the Americas were the regions most affected by chikungunya. Pakistan faced a persistent outbreak that started in the year 2017 and reported 8,387 cases, while India suffered with 62,000 cases. Apart from these, ongoing government initiatives regarding prevention control of mosquito breeding, coupled with rising consciousness among people associated with mosquito bites and its consequences, are also expected to be crucial factors driving market growth in the upcoming years. Furthermore, escalating unmet needs for chikungunya diagnosis in the developing and under-developed regions of Asia and Africa, are projected to further the scope of medical examination possibilities for disease control, which in turn is assessed to offer profitable opportunities to the chikungunya treatment market in the near future.   


Chikungunya Treatment Market Graph
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3573
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of chikungunya treatment is evaluated at USD 1.79 billion.

Chikungunya Treatment Market size was over USD 1.73 billion in 2023 and is poised to cross USD 3.03 billion by 2036, growing at more than 4.4% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing occurrence of chikungunya globally and rising awareness about mosquito-transmitted infections.

Asia Pacific industry is estimated to account for largest revenue share by 2036, driven by growing prevalence of mosquito-transmitted diseases, and rising number of alliances among western market players.

The major players in the market are Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporated., Sanat Products Ltd., Taj Pharmaceuticals Limited., Etubics Corporation, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample